Colorado Animal Specialty & Emergency (CASE)
Research is different in that it looks at the use of diagnostic and treatment options that are not considered part of routine medical care. This may include the administration of novel experimental medications or the use of new diagnostic devices that are being evaluated as possible future routine medical care. It can also include the collection of extra patient samples (i.e., blood, urine, tissue) to be used for research studies at a later date.
By enrolling your pet in a research study, you are committing to helping us improve the way that we care for our patients in the future. Many studies will allow your pet to receive treatment or have a diagnostic procedure performed that would not otherwise be available to them. There will also be many studies in which the study does not immediately benefit your pet, but the data collected will benefit other pets and humans in the future. The potential benefits to your pet will always be discussed by your doctor prior to you electing to enroll your pet in a study.
An indication-seeking pilot study of Paccal Vet in dogs with Splenic Hemangiosarcoma following splenectomy
CURRENTLY ENROLLING
Paclitaxel is one of the most effective anticancer agents used in human cancer today, with potent activity against a wide variety of tumors. Paccal Vet may be a promising treatment option for dogs with hemangiosarcoma.
Autologous canine cancer vaccine with checkpoint inhibitor for treatment of Osteosarcoma
CURRENTLY ENROLLING
The purpose of this study is to evaluate the safety and efficacy of an autologous killed tumor cell vaccine. this trial aims to advance safer, immune-based treatment options for canine cancer that may offer comparable or superior outcomes to chemotherapy.
Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (ePUSH)
CURRENTLY ENROLLING
Is your dog undergoing surgery for a ruptured splenic tumor? Ethos Discovery would love to have you and your dog participate in our clinical trial! We are evaluating drugs for the treatment of HSA with the goal of curing this aggressive cancer.
Exploratory field trial to investigate efficacy and safety of BI705564 in dogs with B-cell Lymphoma
CURRENTLY ENROLLING
The BTK inhibitor BI 705564 has the potential to achieve marked clinical responses in dogs with B-cell malignancies and addresses major unmet needs. These include the expected improvement of quality of life with minimal side effects, increased survival time, oral administration, and affordability.
Negative-controlled pilot field trial to assess the safety and efficacy of a Virus Like Particle (VLP)-Nerve Growth Factor (NGF) vaccine in client-owned dogs with natural occurring osteoarthritis
CURRENTLY ENROLLING
The purpose of this study is to assess the safety and efficacy of a VLP NGF vaccine in dogs with naturally occurring osteoarthritis upon repeated immunization.
Stratification of Outcomes for Lymphoma in Dogs
CURRENTLY ENROLLING
This study focuses on better understanding the genetics behind canine lymphoma. By studying changes in the DNA of these cancers, researchers hope to identify patterns that could lead to more personalized treatment options.
FAQs
How is research different from regular medical care?
Research is different in that it looks at the use of diagnostic and treatment options that are not considered part of routine medical care. This may include the administration of novel experimental medications or the use of new diagnostic devices that are being evaluated as possible future routine medical care. It can also include the collecting of extra patient samples (i.e., blood, urine, tissue) to be used for research studies at a later date.
As a pet owner, what is expected of me if I enroll my pet in a clinical study?
Each study is set up according to its needs. We encourage you to read the guidelines associated with the study you are interested in.
In General:
Compensation for enrolling your pet in a study will differ for each study. Usually, it consists of the diagnostics and treatments that are part of the study being provided to you at no cost. Additionally, there could be other discounts applied to the care of your pet.
In some cases, you may be asked to give medications to your pet, alter their diet, or exercise plans. This will vary for each study. Some studies will require the administration of certain medications or other treatments. Others might require questionnaires to be filled out before or after the study.
The duration of each research study will vary depending on the study design. Simple studies generally require a one-time interaction with a patient with no need for follow up. More comprehensive studies will follow patients over a longer period of time, such as several months or up to one year.
The data collected from your pet will be used to improve the care that we provide to future patients. It will be used to show that a new treatment works with good efficacy or that a novel diagnostic test is accurate. Data collected from patients will be used in scientific publications and presentations in order to inform other veterinarians around the world about the research that we’ve done so they can adopt similar treatments and diagnostics in their practices.
All patient data is anonymized and is not shared with any third parties.
What if I decide to participate in a research study but change my mind at a later date?
All studies provide the option to unenroll your pet at any time. There are no negative consequences should you elect to have them removed from a study.
